CV Sciences, Inc.
CVSI
$0.03
$0.006.15%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -12.20% | -8.04% | -5.50% | -3.46% | -1.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.20% | -8.04% | -5.50% | -3.46% | -1.87% |
| Cost of Revenue | -17.57% | -9.31% | -6.20% | -4.21% | -4.28% |
| Gross Profit | -5.80% | -6.57% | -4.67% | -2.56% | 1.17% |
| SG&A Expenses | -11.91% | -11.07% | -7.13% | -11.82% | -5.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.62% | -13.15% | -9.63% | -11.17% | 43.12% |
| Operating Income | 70.68% | 56.58% | 45.76% | 60.66% | -140.99% |
| Income Before Tax | 60.49% | 41.54% | 38.40% | 41.77% | -177.58% |
| Income Tax Expenses | 212.50% | -133.33% | -133.33% | -- | -33.33% |
| Earnings from Continuing Operations | 59.98% | 41.74% | 38.61% | 41.99% | -177.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.98% | 41.74% | 38.61% | 41.99% | -177.18% |
| EBIT | 70.68% | 56.58% | 45.76% | 60.66% | -140.99% |
| EBITDA | 78.09% | 67.09% | 58.34% | 72.27% | -130.61% |
| EPS Basic | 62.04% | 48.05% | 46.84% | 50.00% | -166.50% |
| Normalized Basic EPS | 47.69% | 39.73% | 28.17% | 57.01% | -143.05% |
| EPS Diluted | 18.98% | 48.39% | 47.17% | 50.24% | -166.83% |
| Normalized Diluted EPS | 47.69% | 39.73% | 28.17% | 57.01% | -143.05% |
| Average Basic Shares Outstanding | 4.98% | 9.33% | 13.69% | 15.40% | 14.01% |
| Average Diluted Shares Outstanding | 4.98% | 9.33% | 13.69% | 15.40% | 14.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |